P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group

Retrovirology

Volumn 6, Issue SUPPL. 3, 2009, Pages

  Scarlatti, G ^a   Alcami, J ^b   Bongertz, V ^c   Fenyo E ^d   Heath, A ^e   Heyndrickx, L ^f   Holmes, H ^e   Jansson, M ^d   Lopalco, L ^a   Malnati, M ^a   Montefiori, D ^g   Moog, C ^h   Morris, L ⁱ   Osmanov, S ^j   Polonis, V ^k   Ramaswamy, M ^e   Sattentau, Q ^l   Schuitemaker, H ^m   Wrin, T ⁿ  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d LUND UNIVERSITY   (Sweden)

^e NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^g DUKE UNIVERSITY   (United States)

^h UNIVERSITÉ DE STRASBOURG   (France)

ⁱ NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m ACADEMIC MEDICAL CENTER   (Netherlands)

ⁿ MONOGRAM BIOSCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449730753     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-S3-P46     Document Type: Note

References (0)